Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
PLoS Genet ; 11(8): e1005352, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26305897

RESUMO

Diabetic kidney disease (DKD) is the most common etiology of chronic kidney disease (CKD) in the industrialized world and accounts for much of the excess mortality in patients with diabetes mellitus. Approximately 45% of U.S. patients with incident end-stage kidney disease (ESKD) have DKD. Independent of glycemic control, DKD aggregates in families and has higher incidence rates in African, Mexican, and American Indian ancestral groups relative to European populations. The Family Investigation of Nephropathy and Diabetes (FIND) performed a genome-wide association study (GWAS) contrasting 6,197 unrelated individuals with advanced DKD with healthy and diabetic individuals lacking nephropathy of European American, African American, Mexican American, or American Indian ancestry. A large-scale replication and trans-ethnic meta-analysis included 7,539 additional European American, African American and American Indian DKD cases and non-nephropathy controls. Within ethnic group meta-analysis of discovery GWAS and replication set results identified genome-wide significant evidence for association between DKD and rs12523822 on chromosome 6q25.2 in American Indians (P = 5.74x10-9). The strongest signal of association in the trans-ethnic meta-analysis was with a SNP in strong linkage disequilibrium with rs12523822 (rs955333; P = 1.31x10-8), with directionally consistent results across ethnic groups. These 6q25.2 SNPs are located between the SCAF8 and CNKSR3 genes, a region with DKD relevant changes in gene expression and an eQTL with IPCEF1, a gene co-translated with CNKSR3. Several other SNPs demonstrated suggestive evidence of association with DKD, within and across populations. These data identify a novel DKD susceptibility locus with consistent directions of effect across diverse ancestral groups and provide insight into the genetic architecture of DKD.


Assuntos
Diabetes Mellitus Tipo 2/genética , Nefropatias Diabéticas/genética , Negro ou Afro-Americano/genética , Diabetes Mellitus Tipo 2/complicações , Nefropatias Diabéticas/etnologia , Predisposição Genética para Doença , Estudo de Associação Genômica Ampla , Hispânico ou Latino/genética , Humanos , Indígenas Norte-Americanos/genética , Proteínas de Ligação a RNA/genética , Estados Unidos , População Branca/genética
2.
Am J Kidney Dis ; 59(2): 210-21, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22119407

RESUMO

BACKGROUND: African Americans have increased susceptibility to nondiabetic nephropathy relative to European Americans. STUDY DESIGN: Follow-up of a pooled genome-wide association study (GWAS) in African American dialysis patients with nondiabetic nephropathy; novel gene-gene interaction analyses. SETTING & PARTICIPANTS: Wake Forest sample: 962 African American nondiabetic nephropathy cases, 931 non-nephropathy controls. Replication sample: 668 Family Investigation of Nephropathy and Diabetes (FIND) African American nondiabetic nephropathy cases, 804 non-nephropathy controls. PREDICTORS: Individual genotyping of top 1,420 pooled GWAS-associated single-nucleotide polymorphisms (SNPs) and 54 SNPs in 6 nephropathy susceptibility genes. OUTCOMES: APOL1 genetic association and additional candidate susceptibility loci interacting with or independently from APOL1. RESULTS: The strongest GWAS associations included 2 noncoding APOL1 SNPs, rs2239785 (OR, 0.33; dominant; P = 5.9 × 10(-24)) and rs136148 (OR, 0.54; additive; P = 1.1 × 10(-7)) with replication in FIND (P = 5.0 × 10(-21) and 1.9 × 10(-05), respectively). rs2239785 remained associated significantly after controlling for the APOL1 G1 and G2 coding variants. Additional top hits included a CFH SNP (OR from meta-analysis in the 3,367 African American cases and controls, 0.81; additive; P = 6.8 × 10(-4)). The 1,420 SNPs were tested for interaction with APOL1 G1 and G2 variants. Several interactive SNPs were detected; the most significant was rs16854341 in the podocin gene (NPHS2; P = 0.0001). LIMITATIONS: Nonpooled GWASs have not been performed in African American patients with nondiabetic nephropathy. CONCLUSIONS: This follow-up of a pooled GWAS provides additional and independent evidence that APOL1 variants contribute to nondiabetic nephropathy in African Americans and identified additional associated and interactive nondiabetic nephropathy susceptibility genes.


Assuntos
Negro ou Afro-Americano/genética , Epistasia Genética/genética , Estudos de Associação Genética , Nefropatias/etnologia , Nefropatias/genética , Diálise Renal , Adulto , Idoso , Apolipoproteína L1 , Apolipoproteínas/genética , Estudos de Casos e Controles , Feminino , Seguimentos , Predisposição Genética para Doença/etnologia , Predisposição Genética para Doença/genética , Genótipo , Humanos , Incidência , Peptídeos e Proteínas de Sinalização Intracelular/genética , Nefropatias/terapia , Lipoproteínas HDL/genética , Masculino , Proteínas de Membrana/genética , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único/genética
4.
Am J Nephrol ; 33(5): 381-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21454968

RESUMO

BACKGROUND: Diabetic nephropathy (DN) is a leading cause of mortality and morbidity in patients with type 1 and type 2 diabetes. The multicenter FIND consortium aims to identify genes for DN and its associated quantitative traits, e.g. the urine albumin:creatinine ratio (ACR). Herein, the results of whole-genome linkage analysis and a sparse association scan for ACR and a dichotomous DN phenotype are reported in diabetic individuals. METHODS: A genomewide scan comprising more than 5,500 autosomal single nucleotide polymorphism markers (average spacing of 0.6 cM) was performed on 1,235 nuclear and extended pedigrees (3,972 diabetic participants) ascertained for DN from African-American (AA), American-Indian (AI), European-American (EA) and Mexican-American (MA) populations. RESULTS: Strong evidence for linkage to DN was detected on chromosome 6p (p = 8.0 × 10(-5), LOD = 3.09) in EA families as well as suggestive evidence for linkage to chromosome 7p in AI families. Regions on chromosomes 3p in AA, 7q in EA, 16q in AA and 22q in MA displayed suggestive evidence of linkage for urine ACR. The linkage peak on chromosome 22q overlaps the MYH9/APOL1 gene region, previously implicated in AA diabetic and nondiabetic nephropathies. CONCLUSION: These results strengthen the evidence for previously identified genomic regions and implicate several novel loci potentially involved in the pathogenesis of DN.


Assuntos
Albuminúria/genética , Nefropatias Diabéticas/genética , Estudo de Associação Genômica Ampla , Insuficiência Renal/genética , Idoso , Albuminúria/metabolismo , Mapeamento Cromossômico , Nefropatias Diabéticas/metabolismo , Etnicidade , Feminino , Ligação Genética , Predisposição Genética para Doença , Humanos , Masculino , Pessoa de Meia-Idade , Linhagem , Polimorfismo de Nucleotídeo Único , Insuficiência Renal/metabolismo , Risco , Fatores de Tempo
5.
Genet Med ; 11(8): 559-67, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19617843

RESUMO

The increasing availability of personal genomic tests has led to discussions about the validity and utility of such tests and the balance of benefits and harms. A multidisciplinary workshop was convened by the National Institutes of Health and the Centers for Disease Control and Prevention to review the scientific foundation for using personal genomics in risk assessment and disease prevention and to develop recommendations for targeted research. The clinical validity and utility of personal genomics is a moving target with rapidly developing discoveries but little translation research to close the gap between discoveries and health impact. Workshop participants made recommendations in five domains: (1) developing and applying scientific standards for assessing personal genomic tests; (2) developing and applying a multidisciplinary research agenda, including observational studies and clinical trials to fill knowledge gaps in clinical validity and utility; (3) enhancing credible knowledge synthesis and information dissemination to clinicians and consumers; (4) linking scientific findings to evidence-based recommendations for use of personal genomics; and (5) assessing how the concept of personal utility can affect health benefits, costs, and risks by developing appropriate metrics for evaluation. To fulfill the promise of personal genomics, a rigorous multidisciplinary research agenda is needed.


Assuntos
Genômica/métodos , Disseminação de Informação/métodos , Humanos , National Institutes of Health (U.S.) , Assistência Individualizada de Saúde/métodos , Estados Unidos
6.
Biopreserv Biobank ; 15(4): 341-343, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28441039

RESUMO

Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up ( www.nih.gov/research-training/allofus-research-program ). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.


Assuntos
Pesquisa Biomédica/educação , Coleta de Amostras Sanguíneas/métodos , Educação , Medicina de Precisão/métodos , Pesquisa Biomédica/tendências , Coleta de Amostras Sanguíneas/normas , Sobrevivência Celular , Humanos , Leucócitos Mononucleares/citologia
7.
Clin J Am Soc Nephrol ; 10(4): 710-5, 2015 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-25376765

RESUMO

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repositories, part of the National Institutes of Health (NIH), are an important resource available to researchers and the general public. The Central Repositories house samples, genetic data, phenotypic data, and study documentation from >100 NIDDK-funded clinical studies, in areas such as diabetes, digestive disease, and liver disease research. The Central Repositories also have an exceptionally rich collection of studies related to kidney disease, including the Modification of Diet in Renal Disease landmark study and recent data from the Chronic Renal Insufficiency Cohort and CKD in Children Cohort studies. The data are carefully curated and linked to the samples from the study. The NIDDK is working to make the materials and data accessible to researchers. The Data Repositories continue to improve flexible online searching tools that help researchers identify the samples or data of interest, and NIDDK has created several different paths to access the data and samples, including some funding initiatives. Over the past several years, the Central Repositories have seen steadily increasing interest and use of the stored materials. NIDDK plans to make more collections available and do more outreach and education about use of the datasets to the nephrology research community in the future to enhance the value of this resource.


Assuntos
Pesquisa Biomédica/métodos , Bases de Dados Factuais , National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) , Nefrologia/métodos , Acesso à Informação , Comportamento Cooperativo , Mineração de Dados , Humanos , Disseminação de Informação , Comunicação Interdisciplinar , Cooperação Internacional , Estados Unidos
8.
Clin J Am Soc Nephrol ; 10(12): 2279-87, 2015 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-26138261

RESUMO

CKD affects an estimated 14% of adults in sub-Saharan Africa, but very little research has been done on the cause, progression, and prevention of CKD there. As part of the Human Heredity and Health in Africa (H3Africa) Consortium, the H3Africa Kidney Disease Research Network was established to study prevalent forms of kidney disease in sub-Saharan Africa and increase the capacity for genetics and genomics research. The study is performing comprehensive phenotypic characterization and analyzing environmental and genetic factors from nine clinical centers in four African countries (Ghana, Nigeria, Ethiopia, and Kenya) over a 5-year period. Approximately 4000 participants with specified kidney disease diagnoses and 4000 control participants will be enrolled in the four African countries. In addition, approximately 50 families with hereditary glomerular disease will be enrolled. The study includes both pediatric and adult participants age <1 to 74 years across a broad spectrum of kidney diseases secondary to hypertension-attributed nephropathy, diabetes, HIV infection, sickle cell disease, biopsy-proven glomerular disease, and CKD of unknown origin. Clinical and demographic data with biospecimens are collected to assess clinical, biochemical, and genetic markers of kidney disease. As of March 2015, a total of 3499 patients and controls have been recruited and 1897 had complete entry data for analysis. Slightly more than half (50.2%) of the cohort is female. Initial quality control of clinical data collection and of biosample and DNA analysis is satisfactory, demonstrating that a clinical research infrastructure can be successfully established in Africa. This study will provide clinical, biochemical, and genotypic data that will greatly increase the understanding of CKD in sub-Saharan Africa.


Assuntos
Pesquisa Biomédica/métodos , Genômica/métodos , Nefrologia/métodos , Insuficiência Renal Crônica/genética , Insuficiência Renal Crônica/terapia , Adolescente , Adulto , África Subsaariana/epidemiologia , Idoso , Pesquisa Biomédica/organização & administração , Estudos de Casos e Controles , Criança , Pré-Escolar , Biologia Computacional , Comportamento Cooperativo , Feminino , Predisposição Genética para Doença , Genômica/organização & administração , Hereditariedade , Humanos , Lactente , Cooperação Internacional , Masculino , Mentores , Pessoa de Meia-Idade , Nefrologia/organização & administração , Linhagem , Fenótipo , Prevalência , Prognóstico , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/epidemiologia , Projetos de Pesquisa , Medição de Risco , Fatores de Risco , Adulto Jovem
9.
Clin J Am Soc Nephrol ; 9(10): 1799-801, 2014 Oct 07.
Artigo em Inglês | MEDLINE | ID: mdl-24903391

RESUMO

Kidney disease is a significant medical and public health problem. The National Institute of Diabetes and Digestive and Kidney Diseases recently asked the community to identify research objectives, which, if addressed, could improve understanding of basic kidney function and aid in prevention, treatment, and reversal of kidney disease. The Kidney Research National Dialogue invited interested parties to submit, discuss, and prioritize ideas using an interactive website; 1600 participants posted more than 300 ideas covering all areas of kidney disease, including the cystic kidney diseases. Although much is known about the genetics and pathogenesis of cystic diseases, there remain challenges to our understanding of the fundamental mechanisms of cyst formation, what genes act as modifiers to cause variable responses in different people, and how to detect and monitor disease progression. This article summarizes key research questions for cystic kidney diseases.


Assuntos
Pesquisa Biomédica/tendências , Nefrologia/tendências , Doenças Renais Policísticas , Animais , Difusão de Inovações , Marcadores Genéticos , Predisposição Genética para Doença , Prioridades em Saúde/tendências , Humanos , Fenótipo , Doenças Renais Policísticas/diagnóstico , Doenças Renais Policísticas/epidemiologia , Doenças Renais Policísticas/genética , Doenças Renais Policísticas/fisiopatologia , Doenças Renais Policísticas/terapia , Valor Preditivo dos Testes , Prognóstico , Medição de Risco , Fatores de Risco
10.
PLoS One ; 8(12): e81888, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24358131

RESUMO

OBJECTIVE: Estimated glomerular filtration rate (eGFR), a measure of kidney function, is heritable, suggesting that genes influence renal function. Genes that influence eGFR have been identified through genome-wide association studies. However, family-based linkage approaches may identify loci that explain a larger proportion of the heritability. This study used genome-wide linkage and association scans to identify quantitative trait loci (QTL) that influence eGFR. METHODS: Genome-wide linkage and sparse association scans of eGFR were performed in families ascertained by probands with advanced diabetic nephropathy (DN) from the multi-ethnic Family Investigation of Nephropathy and Diabetes (FIND) study. This study included 954 African Americans (AA), 781 American Indians (AI), 614 European Americans (EA) and 1,611 Mexican Americans (MA). A total of 3,960 FIND participants were genotyped for 6,000 single nucleotide polymorphisms (SNPs) using the Illumina Linkage IVb panel. GFR was estimated by the Modification of Diet in Renal Disease (MDRD) formula. RESULTS: The non-parametric linkage analysis, accounting for the effects of diabetes duration and BMI, identified the strongest evidence for linkage of eGFR on chromosome 20q11 (log of the odds [LOD] = 3.34; P = 4.4 × 10(-5)) in MA and chromosome 15q12 (LOD = 2.84; P = 1.5 × 10(-4)) in EA. In all subjects, the strongest linkage signal for eGFR was detected on chromosome 10p12 (P = 5.5 × 10(-4)) at 44 cM near marker rs1339048. A subsequent association scan in both ancestry-specific groups and the entire population identified several SNPs significantly associated with eGFR across the genome. CONCLUSION: The present study describes the localization of QTL influencing eGFR on 20q11 in MA, 15q21 in EA and 10p12 in the combined ethnic groups participating in the FIND study. Identification of causal genes/variants influencing eGFR, within these linkage and association loci, will open new avenues for functional analyses and development of novel diagnostic markers for DN.


Assuntos
Nefropatias Diabéticas/genética , Ligação Genética , Taxa de Filtração Glomerular/genética , Nefropatias/genética , Polimorfismo de Nucleotídeo Único , Negro ou Afro-Americano/genética , Idoso , Feminino , Predisposição Genética para Doença , Estudo de Associação Genômica Ampla , Genótipo , Humanos , Indígenas Norte-Americanos/genética , Masculino , Americanos Mexicanos/genética , Pessoa de Meia-Idade , Locos de Características Quantitativas , População Branca/genética
11.
Per Med ; 6(5): 579-588, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29783302

RESUMO

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH, supports a large and varied portfolio of genetic research grants and contracts. As a funding agency, the NIDDK aims to support research that can be translated into discoveries that help to reduce the burden of genetic diseases. Except for the major advances in diagnostics for Mendelian diseases and a few disease-specific therapies, there has only been modest clinical benefit from the investment in human genetics research. For genetically complex, multifactorial diseases, including many of the common diseases in the USA, the risk genes are harder to find than for Mendelian diseases, and translation seems even further off. How can NIDDK make its investment in human genetics research pay off? This report describes the challenges in human genetics research and NIDDK's fivefold funding strategy to support science that will eventually lead to meaningful translation.

12.
Invest Ophthalmol Vis Sci ; 49(9): 3839-45, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18765632

RESUMO

PURPOSE: Diabetic retinopathy (DR) and diabetic nephropathy (DN) are serious microvascular complications of diabetes mellitus. Correlations between severity of DR and DN and computed heritability estimates for DR were determined in a large, multiethnic sample of diabetic families. The hypothesis was that (1) the severity of DR correlates with the presence and severity of nephropathy in individuals with diabetes mellitus, and (2) the severity of DR is under significant familial influence in members of multiplex diabetic families. METHODS: The Family Investigation of Nephropathy and Diabetes (FIND) was designed to evaluate the genetic basis of DN in American Indians, European Americans, African Americans, and Mexican Americans. FIND enrolled probands with advanced DN, along with their diabetic siblings who were concordant and discordant for nephropathy. These diabetic family members were invited to participate in the FIND-Eye study to determine whether inherited factors underlie susceptibility to DR and its severity. FIND-Eye participants underwent eye examinations and had fundus photographs taken. The severity of DR was graded by using the Early Treatment Diabetic Retinopathy Study Classification (ETDRS). Sib-sib correlations were calculated with the SAGE 5.0 program FCOR, to estimate heritability of retinopathy severity. RESULTS: This report summarizes the results for the first 2368 diabetic subjects from 767 families enrolled in FIND-Eye; nearly 50% were Mexican American, the largest single ethnicity within FIND. The overall prevalence of DR was high; 33.4% had proliferative DR; 7.5%, 22.8%, and 9.5% had severe, moderate, and mild nonproliferative DR, respectively; 26.6% had no DR. The severity of DR was significantly associated with severity of DN, both by phenotypic category and by increasing serum creatinine concentration (chi(2) = 658.14, df = 20; P < 0.0001). The sib-sib correlation for DR severity was 0.1358 in the total sample and 0.1224 when limited to the Mexican-American sample. Broad sense heritabilities for DR were 27% overall and 24% in Mexican-American families. The polygenic heritability of liability for proliferative DR approximated 25% in this FIND-Eye sample. CONCLUSIONS: These data confirm that the severity of DR parallels the presence and severity of nephropathy in individuals with diabetes mellitus. The severity of DR in members of multiplex diabetic families appears to have a significant familial connection.


Assuntos
Nefropatias Diabéticas/genética , Retinopatia Diabética/genética , Retinopatia Diabética/fisiopatologia , Família , Creatinina/sangue , Angiopatias Diabéticas/fisiopatologia , Nefropatias Diabéticas/fisiopatologia , Retinopatia Diabética/diagnóstico , Etnicidade , Feminino , Angiofluoresceinografia , Humanos , Masculino , Microcirculação , Fenótipo , Grupos Raciais , Índice de Gravidade de Doença , Irmãos
13.
Zebrafish ; 1(2): 105-10, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-18248222

RESUMO

The National Institutes of Health (NIH), an agency in the Department of Health and Human Services (DHHS), is a strong advocate of zebrafish and other animal model systems for biomedical and behavior research. In part because of strong funding support from NIH, zebrafish research is now providing fundamental insights into physiology, behavior, and the mechanisms of human disease. Over the past few years, the NIH has established a research infrastructure for the zebrafish community that includes genomic resources and tools for genetic analysis in this system. In addition, the NIH supports community resources such as the Zebrafish International Resource Center (ZIRC) and the Zebrafish Information Network (ZFIN). With the importance of zebrafish research now well-established, NIH will continue to fund a broad array of investigator-initiated studies that focus on issues critical to human health using this model system.

14.
Dev Dyn ; 228(3): 490-6, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14579387

RESUMO

The National Institutes of Health (NIH) has been a leading advocate of the zebrafish as a model organism for the study of vertebrate development, physiology, and disease. Genomic tools, developed with the support of NIH funding, have made zebrafish even more attractive as a genetic system and have stimulated research using this model. The NIH continues to provide support for new and existing community resources, such as the Zebrafish International Resource Center and the Zebrafish Information Network, research tool development and mutant screens, and a wide array of investigator-initiated studies that are using zebrafish to elucidate many aspects of vertebrate biology.


Assuntos
Genoma , National Institutes of Health (U.S.) , Projetos de Pesquisa , Peixe-Zebra/genética , Animais , Encéfalo/fisiologia , Genômica , Pesquisa/organização & administração , Pesquisa/tendências , Apoio à Pesquisa como Assunto , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA